Literature DB >> 25122782

Probing the functions of the paramyxovirus glycoproteins F and HN with a panel of synthetic antibodies.

Brett D Welch1, Marcin Paduch2, George P Leser1, Zachary Bergman3, Christopher A Kors1, Reay G Paterson3, Theodore S Jardetzky4, Anthony A Kossiakoff5, Robert A Lamb6.   

Abstract

Paramyxoviruses are enveloped negative-strand RNA viruses that are significant human and animal pathogens. Most paramyxoviruses infect host cells via the concerted action of a tetrameric attachment protein (variously called HN, H, or G) that binds either sialic acid or protein receptors on target cells and a trimeric fusion protein (F) that merges the viral envelope with the plasma membrane at neutral pH. F initially folds to a metastable prefusion conformation that becomes activated via a cleavage event during cellular trafficking. Upon receptor binding, the attachment protein, which consists of a globular head anchored to the membrane via a helical tetrameric stalk, triggers a major conformation change in F which results in fusion of virus and host cell membranes. We recently proposed a model for F activation in which the attachment protein head domains move following receptor binding to expose HN stalk residues critical for triggering F. To test the model in the context of wild-type viral glycoproteins, we used a restricted-diversity combinatorial Fab library and phage display to rapidly generate synthetic antibodies (sAbs) against multiple domains of the paramyxovirus parainfluenza 5 (PIV5) pre- and postfusion F and HN. As predicted by the model, sAbs that bind to the critical F-triggering region of the HN stalk do not disrupt receptor binding or neuraminidase (NA) activity but are potent inhibitors of fusion. An inhibitory prefusion F-specific sAb recognized a quaternary antigenic site and may inhibit fusion by preventing F refolding or by blocking the F-HN interaction. Importance: The paramyxovirus family of negative-strand RNA viruses cause significant disease in humans and animals. The viruses bind to cells via their receptor binding protein and then enter cells by fusion of their envelope with the host cell plasma membrane, a process mediated by a metastable viral fusion (F) protein. To understand the steps in viral membrane fusion, a library of synthetic antibodies to F protein and the receptor binding protein was generated in bacteriophage. These antibodies bound to different regions of the F protein and the receptor binding protein, and the location of antibody binding affected different processes in viral entry into cells.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122782      PMCID: PMC4178754          DOI: 10.1128/JVI.01707-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.

Authors:  S Crennell; T Takimoto; A Portner; G Taylor
Journal:  Nat Struct Biol       Date:  2000-11

2.  A cell fusion-inhibiting monoclonal antibody binds to the presumed stalk domain of the human parainfluenza type 2 virus hemagglutinin-neuraminidase protein.

Authors:  T Yuasa; M Kawano; N Tabata; M Nishio; S Kusagawa; H Komada; H Matsumura; Y Ito; M Tsurudome
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

3.  Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cells.

Authors:  Sayantan Bose; Albert S Song; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

4.  Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces.

Authors:  Q Yao; X Hu; R W Compans
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Strength of envelope protein interaction modulates cytopathicity of measles virus.

Authors:  Richard K Plemper; Anthea L Hammond; Denis Gerlier; Adele K Fielding; Roberto Cattaneo
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  A stabilized headless measles virus attachment protein stalk efficiently triggers membrane fusion.

Authors:  Melinda A Brindley; Rolf Suter; Isabel Schestak; Gabriella Kiss; Elizabeth R Wright; Richard K Plemper
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

7.  Mutations in the parainfluenza virus 5 fusion protein reveal domains important for fusion triggering and metastability.

Authors:  Sayantan Bose; Carissa M Heath; Priya A Shah; Maher Alayyoubi; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

8.  Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike.

Authors:  R Deng; Z Wang; A M Mirza; R M Iorio
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

9.  Specific structural alteration of the influenza haemagglutinin by amantadine.

Authors:  R J Sugrue; G Bahadur; M C Zambon; M Hall-Smith; A R Douglas; A J Hay
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

10.  Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced Nipah virus fusion and cell entry.

Authors:  Qian Liu; Jacquelyn A Stone; Birgit Bradel-Tretheway; Jeffrey Dabundo; Javier A Benavides Montano; Jennifer Santos-Montanez; Scott B Biering; Anthony V Nicola; Ronald M Iorio; Xiaonan Lu; Hector C Aguilar
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

View more
  7 in total

Review 1.  Antivirals targeting paramyxovirus membrane fusion.

Authors:  Erik M Contreras; Isaac Abrrey Monreal; Martin Ruvalcaba; Victoria Ortega; Hector C Aguilar
Journal:  Curr Opin Virol       Date:  2021-09-27       Impact factor: 7.090

2.  Immobilization of the N-terminal helix stabilizes prefusion paramyxovirus fusion proteins.

Authors:  Albert S Song; Taylor A Poor; Luciano A Abriata; Theodore S Jardetzky; Matteo Dal Peraro; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-22       Impact factor: 11.205

Review 3.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

Review 4.  Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry.

Authors:  Sayantan Bose; Theodore S Jardetzky; Robert A Lamb
Journal:  Virology       Date:  2015-03-12       Impact factor: 3.616

5.  Sequential conformational changes in the morbillivirus attachment protein initiate the membrane fusion process.

Authors:  Nadine Ader-Ebert; Mojtaba Khosravi; Michael Herren; Mislay Avila; Lisa Alves; Fanny Bringolf; Claes Örvell; Johannes P Langedijk; Andreas Zurbriggen; Richard K Plemper; Philippe Plattet
Journal:  PLoS Pathog       Date:  2015-05-06       Impact factor: 6.823

Review 6.  Protein Engineering: Advances in Phage Display for Basic Science and Medical Research.

Authors:  Elena K Davydova
Journal:  Biochemistry (Mosc)       Date:  2022-01       Impact factor: 2.487

7.  Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses.

Authors:  Tianyan Liu; Yu Zhang; Yukai Cao; Shan Jiang; Rui Sun; Jiechao Yin; Zhenqiu Gao; Guiping Ren; Zhenzhong Wang; Qingzhong Yu; Guangchao Sui; Xu Sun; Wenying Sun; Wei Xiao; Deshan Li
Journal:  Gene Ther       Date:  2020-05-14       Impact factor: 5.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.